Immediate Impact

49 standout
Sub-graph 1 of 24

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
25 intermediate papers

Works of Daniel Foltys being referenced

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
2012
Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
2012
and 4 more

Author Peers

Author Last Decade Papers Cites
Daniel Foltys 485 383 307 22 717
P. Wolf 322 240 276 40 779
Tanous D. Faris 439 221 167 23 690
A. Mayer 512 251 278 16 721
S Todo 458 134 122 12 622
A Jain 362 370 168 26 785
Sigrid Bachmann 475 253 336 18 706
Christopher Burghuber 298 309 111 26 601
Angello Lin 311 264 59 31 835
Roberto Troisi 359 161 360 33 598
Olga Millán 298 474 105 45 829

All Works

Loading papers...

Rankless by CCL
2026